Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -203,417 | -165,286 | -85,708 | -44,720 | -166,247 |
| Depreciation Amortization | 27,289 | 20,400 | 13,371 | 6,840 | 29,640 |
| Accounts receivable | -8,704 | -8,873 | -2,050 | 1,025 | -4,567 |
| Accounts payable and accrued liabilities | -450 | -200 | 2,769 | 1,814 | -5,646 |
| Other Working Capital | -52,073 | -62,121 | -40,379 | -18,597 | -12,741 |
| Other Operating Activity | 65,301 | 51,029 | 3,257 | -1,192 | 17,444 |
| Operating Cash Flow | $-172,054 | $-165,051 | $-108,740 | $-54,830 | $-142,117 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,959 | -11,817 | -7,383 | -3,239 | -12,538 |
| Purchase Of Investment | -236,548 | -149,055 | -48,637 | -24,860 | -148,642 |
| Sale Of Investment | 243,410 | 187,964 | 133,897 | 63,964 | 292,351 |
| Other Investing Activity | 8,365 | 3,240 | 840 | 840 | -23,786 |
| Investing Cash Flow | $-1,732 | $30,332 | $78,717 | $36,705 | $107,385 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -12,563 |
| Common Stock Issued | 197,591 | 181,860 | 170,046 | 572 | 8,742 |
| Other Financing Activity | -135 | -45 | 0 | 0 | -4,805 |
| Financing Cash Flow | $197,456 | $181,815 | $170,046 | $572 | $-8,626 |
| Exchange Rate Effect | -631 | -483 | -334 | -82 | 205 |
| Beginning Cash Position | 55,006 | 55,006 | 55,006 | 55,006 | 98,159 |
| End Cash Position | 78,045 | 101,619 | 194,695 | 37,371 | 55,006 |
| Net Cash Flow | $23,039 | $46,613 | $139,689 | $-17,635 | $-43,153 |
| Free Cash Flow | |||||
| Operating Cash Flow | -172,054 | -165,051 | -108,740 | -54,830 | -142,117 |
| Capital Expenditure | -16,959 | -11,817 | -7,383 | -3,239 | -12,538 |
| Free Cash Flow | -189,013 | -176,868 | -116,123 | -58,069 | -154,655 |